180 related articles for article (PubMed ID: 23064977)
1. Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells.
Costa N; Pires AE; Gabriel AM; Goulart LF; Pereira C; Leal B; Queiros AC; Chaara W; Moraes-Fontes MF; Vasconcelos C; Ferreira C; Martins J; Bastos M; Santos MJ; Pereira MA; Martins B; Lima M; João C; Six A; Demengeot J; Fesel C
J Clin Immunol; 2013 Feb; 33(2):349-60. PubMed ID: 23064977
[TBL] [Abstract][Full Text] [Related]
2. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
3. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of regulatory T cell abnormalities and variational usage of TCR repertoire in children with autoimmune neutropenia.
Goda S; Hayakawa S; Karakawa S; Okada S; Kawaguchi H; Kobayashi M
Clin Exp Immunol; 2021 Apr; 204(1):1-13. PubMed ID: 33289074
[TBL] [Abstract][Full Text] [Related]
5. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
6. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
9. Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives.
Costa N; Marques O; Godinho SI; Carvalho C; Leal B; Figueiredo AM; Vasconcelos C; Marinho A; Moraes-Fontes MF; Gomes da Costa A; Ponte C; Campanilho-Marques R; Cóias T; Martins AR; Viana JF; Lima M; Martins B; Fesel C
Clin Exp Immunol; 2017 Sep; 189(3):318-330. PubMed ID: 28542701
[TBL] [Abstract][Full Text] [Related]
10. Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.
Hirabayashi Y; Takahashi Y; Xu Y; Akane K; Villalobos IB; Okuno Y; Hasegawa S; Muramatsu H; Hama A; Kato T; Kojima S
Eur J Pediatr; 2013 Jun; 172(6):833-7. PubMed ID: 23340699
[TBL] [Abstract][Full Text] [Related]
11. Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.
Tjon AS; Tha-In T; Metselaar HJ; van Gent R; van der Laan LJ; Groothuismink ZM; te Boekhorst PA; van Hagen PM; Kwekkeboom J
Clin Exp Immunol; 2013 Aug; 173(2):259-67. PubMed ID: 23607448
[TBL] [Abstract][Full Text] [Related]
12. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
13. Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.
Horwitz DA
Arthritis Res Ther; 2010; 12(1):101. PubMed ID: 20122288
[TBL] [Abstract][Full Text] [Related]
14. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
15. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
16. The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study.
Tselios K; Sarantopoulos A; Gkougkourelas I; Boura P
Scand J Rheumatol; 2015; 44(1):29-35. PubMed ID: 25205084
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants.
Barreto M; Ferreira RC; Lourenço L; Moraes-Fontes MF; Santos E; Alves M; Carvalho C; Martins B; Andreia R; Viana JF; Vasconcelos C; Mota-Vieira L; Ferreira C; Demengeot J; Vicente AM
BMC Immunol; 2009 Jan; 10():5. PubMed ID: 19173720
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
[TBL] [Abstract][Full Text] [Related]
19. Increased CD4
Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
[TBL] [Abstract][Full Text] [Related]
20. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
Xing Q; Su H; Cui J; Wang B
Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
